Cargando…
Suppression of experimental cerebral malaria by disruption of malate:quinone oxidoreductase
BACKGROUND: Aspartate, which is converted from oxaloacetate (OAA) by aspartate aminotransferase, is considered an important precursor for purine salvage and pyrimidine de novo biosynthesis, and is thus indispensable for the growth of Plasmodium parasites at the asexual blood stages. OAA can be produ...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5469008/ https://www.ncbi.nlm.nih.gov/pubmed/28606087 http://dx.doi.org/10.1186/s12936-017-1898-5 |
_version_ | 1783243501721354240 |
---|---|
author | Niikura, Mamoru Komatsuya, Keisuke Inoue, Shin-Ichi Matsuda, Risa Asahi, Hiroko Inaoka, Daniel Ken Kita, Kiyoshi Kobayashi, Fumie |
author_facet | Niikura, Mamoru Komatsuya, Keisuke Inoue, Shin-Ichi Matsuda, Risa Asahi, Hiroko Inaoka, Daniel Ken Kita, Kiyoshi Kobayashi, Fumie |
author_sort | Niikura, Mamoru |
collection | PubMed |
description | BACKGROUND: Aspartate, which is converted from oxaloacetate (OAA) by aspartate aminotransferase, is considered an important precursor for purine salvage and pyrimidine de novo biosynthesis, and is thus indispensable for the growth of Plasmodium parasites at the asexual blood stages. OAA can be produced in malaria parasites via two routes: (i) from phosphoenolpyruvate (PEP) by phosphoenolpyruvate carboxylase (PEPC) in the cytosol, or (ii) from fumarate by consecutive reactions catalyzed by fumarate hydratase (FH) and malate:quinone oxidoreductase (MQO) in the mitochondria of malaria parasites. Although PEPC-deficient Plasmodium falciparum and Plasmodium berghei (rodent malaria) parasites show a growth defect, the mutant P. berghei can still cause experimental cerebral malaria (ECM) with similar dynamics to wild-type parasites. In contrast, the importance of FH and MQO for parasite viability, growth and virulence is not fully understood because no FH- and MQO-deficient P. falciparum has been established. In this study, the role of FH and MQO in the pathogenicity of asexual-blood-stage Plasmodium parasites causing cerebral malaria was examined. RESULTS: First, FH- and MQO-deficient parasites were generated by inserting a luciferase-expressing cassette into the fh and mqo loci in the genome of P. berghei ANKA strain. Second, the viability of FH-deficient and MQO-deficient parasites that express luciferase was determined by measuring luciferase activity, and the effect of FH or MQO deficiency on the development of ECM was examined. While the viability of FH-deficient P. berghei was comparable to that of control parasites, MQO-deficient parasites exhibited considerably reduced viability. FH activity derived from erythrocytes was also detected. This result and the absence of phenotype in FH-deficient P. berghei parasites suggest that fumarate can be metabolized to malate by host or parasite FH in P. berghei-infected erythrocytes. Furthermore, although the growth of FH- and MQO-deficient parasites was impaired, the development of ECM was suppressed only in mice infected with MQO-deficient parasites. CONCLUSIONS: These findings suggest that MQO-mediated mitochondrial functions are required for development of ECM of asexual-blood-stage Plasmodium parasites. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s12936-017-1898-5) contains supplementary material, which is available to authorized users. |
format | Online Article Text |
id | pubmed-5469008 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-54690082017-06-14 Suppression of experimental cerebral malaria by disruption of malate:quinone oxidoreductase Niikura, Mamoru Komatsuya, Keisuke Inoue, Shin-Ichi Matsuda, Risa Asahi, Hiroko Inaoka, Daniel Ken Kita, Kiyoshi Kobayashi, Fumie Malar J Research BACKGROUND: Aspartate, which is converted from oxaloacetate (OAA) by aspartate aminotransferase, is considered an important precursor for purine salvage and pyrimidine de novo biosynthesis, and is thus indispensable for the growth of Plasmodium parasites at the asexual blood stages. OAA can be produced in malaria parasites via two routes: (i) from phosphoenolpyruvate (PEP) by phosphoenolpyruvate carboxylase (PEPC) in the cytosol, or (ii) from fumarate by consecutive reactions catalyzed by fumarate hydratase (FH) and malate:quinone oxidoreductase (MQO) in the mitochondria of malaria parasites. Although PEPC-deficient Plasmodium falciparum and Plasmodium berghei (rodent malaria) parasites show a growth defect, the mutant P. berghei can still cause experimental cerebral malaria (ECM) with similar dynamics to wild-type parasites. In contrast, the importance of FH and MQO for parasite viability, growth and virulence is not fully understood because no FH- and MQO-deficient P. falciparum has been established. In this study, the role of FH and MQO in the pathogenicity of asexual-blood-stage Plasmodium parasites causing cerebral malaria was examined. RESULTS: First, FH- and MQO-deficient parasites were generated by inserting a luciferase-expressing cassette into the fh and mqo loci in the genome of P. berghei ANKA strain. Second, the viability of FH-deficient and MQO-deficient parasites that express luciferase was determined by measuring luciferase activity, and the effect of FH or MQO deficiency on the development of ECM was examined. While the viability of FH-deficient P. berghei was comparable to that of control parasites, MQO-deficient parasites exhibited considerably reduced viability. FH activity derived from erythrocytes was also detected. This result and the absence of phenotype in FH-deficient P. berghei parasites suggest that fumarate can be metabolized to malate by host or parasite FH in P. berghei-infected erythrocytes. Furthermore, although the growth of FH- and MQO-deficient parasites was impaired, the development of ECM was suppressed only in mice infected with MQO-deficient parasites. CONCLUSIONS: These findings suggest that MQO-mediated mitochondrial functions are required for development of ECM of asexual-blood-stage Plasmodium parasites. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s12936-017-1898-5) contains supplementary material, which is available to authorized users. BioMed Central 2017-06-12 /pmc/articles/PMC5469008/ /pubmed/28606087 http://dx.doi.org/10.1186/s12936-017-1898-5 Text en © The Author(s) 2017 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Research Niikura, Mamoru Komatsuya, Keisuke Inoue, Shin-Ichi Matsuda, Risa Asahi, Hiroko Inaoka, Daniel Ken Kita, Kiyoshi Kobayashi, Fumie Suppression of experimental cerebral malaria by disruption of malate:quinone oxidoreductase |
title | Suppression of experimental cerebral malaria by disruption of malate:quinone oxidoreductase |
title_full | Suppression of experimental cerebral malaria by disruption of malate:quinone oxidoreductase |
title_fullStr | Suppression of experimental cerebral malaria by disruption of malate:quinone oxidoreductase |
title_full_unstemmed | Suppression of experimental cerebral malaria by disruption of malate:quinone oxidoreductase |
title_short | Suppression of experimental cerebral malaria by disruption of malate:quinone oxidoreductase |
title_sort | suppression of experimental cerebral malaria by disruption of malate:quinone oxidoreductase |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5469008/ https://www.ncbi.nlm.nih.gov/pubmed/28606087 http://dx.doi.org/10.1186/s12936-017-1898-5 |
work_keys_str_mv | AT niikuramamoru suppressionofexperimentalcerebralmalariabydisruptionofmalatequinoneoxidoreductase AT komatsuyakeisuke suppressionofexperimentalcerebralmalariabydisruptionofmalatequinoneoxidoreductase AT inoueshinichi suppressionofexperimentalcerebralmalariabydisruptionofmalatequinoneoxidoreductase AT matsudarisa suppressionofexperimentalcerebralmalariabydisruptionofmalatequinoneoxidoreductase AT asahihiroko suppressionofexperimentalcerebralmalariabydisruptionofmalatequinoneoxidoreductase AT inaokadanielken suppressionofexperimentalcerebralmalariabydisruptionofmalatequinoneoxidoreductase AT kitakiyoshi suppressionofexperimentalcerebralmalariabydisruptionofmalatequinoneoxidoreductase AT kobayashifumie suppressionofexperimentalcerebralmalariabydisruptionofmalatequinoneoxidoreductase |